Efficacy and safety of ixekizumab versus adalimumab in patients with active psoriatic arthritis and moderate-to-severe psoriasis: 52-week results from the randomised SPIRIT-H2H trial

Introduction: The randomised, open-label, assessor-blinded, parallel-group SPIRIT-H2H trial (NCT03151551) demonstrated superiority of ixekizumab over adalimumab in simultaneously achieving improvement in joint symptoms (American College of Rheumatology [ACR]50) and clearance of skin lesions (Psorias...

Full description

Saved in:
Bibliographic Details
Main Authors: Kristian Reich (Author), Lars Erik Kristensen (Author), Saxon D. Smith (Author), Phoebe Rich (Author), Christophe Sapin (Author), Soyi Liu Leage (Author), Robert McKenzie (Author), Christopher Schuster (Author), Elisabeth Riedl (Author), Melinda Gooderham (Author)
Format: Book
Published: Mattioli1885, 2022-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available